Today: 9 April 2026
Browse Category

NYSE:DHI 20 October 2025 - 11 January 2026

Lennar stock jumps nearly 9% on Trump’s $200 billion mortgage-bond push — what to watch next

Lennar stock jumps nearly 9% on Trump’s $200 billion mortgage-bond push — what to watch next

Lennar Corp surged 8.85% to $119.25 Friday, leading U.S. homebuilders higher after President Trump ordered $200 billion in mortgage bond purchases. Treasury Secretary Scott Bessent said the move aims to offset the Fed’s MBS roll-off. Analysts expect the plan to lower mortgage rates by 10–25 basis points. Wall Street questioned whether Fannie Mae and Freddie Mac will remain under government control.
Meritage Homes stock jumps 10% on Trump mortgage-bond order — what to watch next week

Meritage Homes stock jumps 10% on Trump mortgage-bond order — what to watch next week

Meritage Homes surged 10.4% to $75.45 after President Trump ordered $200 billion in mortgage bond purchases, aiming to lower rates. Fannie Mae and Freddie Mac will handle the buys, but details remain unclear. New housing data showed single-family starts up 5.4% in October, while permits dipped 0.5%. The Consumer Price Index for December is due Jan. 13.
Home Depot stock pops on Trump’s $200 billion mortgage-bond order — what Wall Street watches next

Home Depot stock pops on Trump’s $200 billion mortgage-bond order — what Wall Street watches next

Home Depot shares jumped 4.2% to $374.64 Friday after President Donald Trump ordered $200 billion in mortgage-bond purchases, sparking a rally in housing-linked stocks. The Philadelphia Housing index rose 4.8%. Analysts said the plan may cut mortgage rates by up to 0.15 percentage point. Investors await the Fed’s Jan. 27-28 meeting and Home Depot’s Feb. 24 results.
Opendoor stock jumps 13% as Trump orders $200B mortgage bond buys — what investors watch next

Opendoor stock jumps 13% as Trump orders $200B mortgage bond buys — what investors watch next

Opendoor Technologies shares jumped 13.2% to $7.29 Friday after President Trump ordered $200 billion in mortgage bond purchases. The stock saw heavy trading, with 167 million shares changing hands. Analysts said the move could lower mortgage rates, boosting housing stocks including Rocket Companies, Lennar, and D.R. Horton. Investors await details on the bond buys and Opendoor’s next earnings report, expected Feb. 26.
Mortgage rates today hold near 6.2% as D.R. Horton stock slides before jobs report

Mortgage rates today hold near 6.2% as D.R. Horton stock slides before jobs report

D.R. Horton shares fell 3.6% premarket after Citizens downgraded the homebuilder, citing aggressive earnings estimates and inventory risks. The average U.S. 30-year fixed mortgage rate edged up to 6.163%. Lennar dropped 2.3% and the iShares U.S. Home Construction ETF lost 2.4%. Traders awaited Friday’s U.S. jobs report, seen as a key driver for rates.
JPMorgan slashes KB Home target to $50 as Wall Street flags weaker 2026 returns

JPMorgan slashes KB Home target to $50 as Wall Street flags weaker 2026 returns

JPMorgan cut its KB Home price target to $50 from $71 and lowered 2026 and 2027 earnings estimates after the company’s fiscal Q4 report. KB Home’s 2026 return on equity is projected at 6%, down from 11% in 2025. Shares fell 0.3% to $57.16 in morning trading. Fiscal Q4 earnings per share dropped to $1.92 from $2.52 a year earlier, with revenue down 15.5% to $1.69 billion.
US 10-Year Treasury Yield Skyrockets to 17-Year High – Markets and Mortgage Rates on Edge

US 10-Year Treasury Yield Skyrockets to 17-Year High – Markets and Mortgage Rates on Edge

The U.S. 10-year Treasury yield jumped to 4.01% on Oct. 17, 2025, its highest in nearly 17 years, after briefly spiking to 4.85% on hot inflation data. The 30-year fixed mortgage rate climbed to 6.23%. Wall Street closed higher, but volatility increased and gold prices fell. Fed Chair Jerome Powell signaled a possible end to balance-sheet runoff but stressed caution as inflation persists.

Stock Market Today

  • AbbVie's Humira Launch on TrumpRx with 86% Discount Sparks Valuation Questions
    April 9, 2026, 9:02 AM EDT. AbbVie (NYSE:ABBV) has introduced Humira on the TrumpRx platform at an 86% discount under a White House pricing deal aiming to reduce patient costs and widen drug access. This marks a significant US pricing strategy shift post exclusivity for Humira, a key immunology therapy driving substantial revenue. The stock trades near $206.69, about 20% below analyst targets and 43.8% under fair value estimates. The deep discount could alter patient volume, payer ties, and pricing benchmarks in government-linked drug programs. AbbVie's revenue exposure of $61.2 billion and a high price-to-earnings ratio of 87.3 place focus on potential impacts to cash flow and dividends amid its debt load. Investors should monitor reactions from payers, competitors, and capital markets to this pricing shift that could redefine AbbVie's US market dynamics.

Latest article

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

9 April 2026
Brent crude rebounded 3% Thursday despite a U.S.-Iran ceasefire, with the Strait of Hormuz still nearly shut and only one oil-products tanker passing in 24 hours. U.S. gasoline averaged $4.166 a gallon on April 9, and AAA said prices could drop slowly. North Sea Forties crude hit a record $146.43 a barrel. The U.S. EIA expects Hormuz flows may take months to recover.
CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

9 April 2026
CoreWeave said Meta Platforms committed about $21 billion for AI cloud capacity through December 2032. Shares rose 4.3% to $88.90 in premarket trading after the announcement. The deal follows an $8.5 billion loan facility and a $1.25 billion senior notes offering. CoreWeave reported $5.13 billion in 2025 revenue and ended December with a $66.8 billion backlog.
NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

9 April 2026
TrendForce said April 8 that Nvidia’s Rubin AI chip shipments may be delayed by HBM4 memory qualification and cooling demands, shifting over 70% of 2026 high-end GPU volume to the current Blackwell line. Rubin’s projected share dropped to 22%. Samsung began shipping HBM4 to Nvidia in February, but SK Hynix and Micron face qualification delays. Broadcom signed a long-term deal to develop Google’s TPUs through 2031.
Go toTop